Commentary

Video

Challenges With CAR T-Cell Therapies in T-Cell Lymphomas

Author(s):

Jasmine Zain, MD

Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.

Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.

Related Videos
Amrita Krishnan, MD, executive medical director, Hematology, director, Judy and Bernard Briskin Multiple Myeloma Center, professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Idoroenyi Amanam, MD
Francisco Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine—Lymphoma; director, Lymphoma Research, head, Lymphoma Translational Research Lab; associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Justin Kaner, MD
Amitkumar Mehta, MD
Saro H. Armenian, DO, MPH
A panel of 3 experts on nasopharyngeal carcinoma
Saro H. Armenian, DO, MPH
Idoroenyi Amanam, MD
A panel of 3 experts on nasopharyngeal carcinoma
Related Content
CAR T-Cell Therapy in R/R Mantle Cell Lymphoma | Image Credit: © Dr_Microbe - stock.adobe.com
October 14th 2024

Meta-Analysis Shows Efficacy, Safety of CAR T-Cell Therapy in R/R Mantle Cell Lymphoma

Ravi Salgia, MD, PhD, professor, chair, Department of Medical Oncology & Therapeutics Research, Arthur & Rosalie Kaplan Chair in Medical Oncology & Therapeutics Research, City of Hope
September 2nd 2024

Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

Grzegorz S. Nowakowski, MD, consultant, Division of Hematology, enterprise deputy director, Clinical Research, Mayo Clinic Comprehensive Cancer Center
October 7th 2024

Emavusertib Plus Ibrutinib Is Under Investigation in the TakeAim Trial in PCNSL

Oncology Unplugged
August 21st 2024

Park and Kasi Expand on Perioperative Immunotherapy Updates in CRC

Grzegorz S. Nowakowski, MD, consultant, Division of Hematology, enterprise deputy director, Clinical Research, Mayo Clinic Comprehensive Cancer Center
October 4th 2024

Emavusertib-Focused Research Is Poised to Expand the PCNSL Treatment Paradigm

Saro H. Armenian, DO, MPH, Barron Hilton Chair of Pediatrics, a chair and professor, Department of Pediatrics, director and professor, Division of Outcomes Research/Intervention, Department of Population Sciences, director, Center for Survivorship and Outcomes, Hematologic Malignancies Research Institute, City of Hope
October 2nd 2024

Uncovering and Addressing Unmet Needs in Pediatric Cancer Care